Saturday , 4 May 2024

Author Archives: rameshdhani1665

Formulation and In-Vitro Evaluation of Cycllophosphamide Self Nano Emulsifying Drug Delivery System

Rachana N, Ramesh K, Dr. Vijaykumar G, Kishore K KGR Institute of Technology and Management, Rampally, Keesara, Rangareddy, Telangana, India. A B S T R A C T Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ... Read More »

Formulation and In-Vitro Evaluation of Selegiline Buccal Patches

Samhitha M1, Ramesh K2, Dr. Gampa Vijay kumar3, Kishore K4 Department of Pharmaceutics, KGR Institute of Technology and Management, Rampally, Keesara, Rangareddy, Telangana, India Abstract Selegiline, also known as L-deprenyl, is a medication which is used in the treatment of Parkinson’s disease and major depressive disorder. It is provided in the form of a capsule or tablet taken by mouth ... Read More »

Comparative Study on Effect of Natural and Synthetic Super Disintegrants in the Formulation of Haloperidol Fast Dissolving Tablets

A. Pranitha1, Dr. V. Anjaneyulu2, Dr. Gampa Vijay Kumar3 1,2,3KGR Institute of Technology and Management, Rampally, Keesara, Rangareddy, Telangana, India. A B S T R A C T Haloperidol is a typical antipsychotic medication. Haloperidol is used in the treatment of schizophrenia, tics in Tourette syndrome, mania in bipolar disorder, delirium, agitation, acute psychosis, and hallucinations in alcohol withdrawal. It ... Read More »

Case Studies of the Development of Russian Regulatory Legislation and Marketing Authorization of a Herbal Medicinal Product in CIS Countries As Compared to the EU Regulatory Frame

D. Chandanapriya, M. Kishorebabu, J. Praveen kumar Krishna Teja Pharmacy College, Tirupati, Andhra Pradesh, India A B S T R A C T A European study on current regulatory legislation in the CIS Countries & Marketing authorization of herbal medicinal products in CIS countries was done for comparing the current regulations of both in CIS countries along with EU regulations ... Read More »

Ce Certification Process of Medical Devices in Eu as Per Regulatory Needs

Rajkiran Kolakota, K. Padmaja* 1-2Department of Pharmaceutical Regulatory Affairs, Sri Sivani college of Pharmacy, NH-16, Chilakapalem Jn, Srikakulam-532402, AP. A  B  S  T  R  A  C T The EU introduced the CE marking scheme to make trade easier and cheaper between EU countries. It means that a manufacturer claims that their product conforms to the minimum legal requirements for health ... Read More »

Registration Steps Followed for Filing of Biosimilars in Regulated and Emerging Markets

Rajkiran Kolakota1 and I. Jhansi Lakshmi*2 1-2Department of Pharmaceutical Regulatory Affairs, Sri Sivani College of Pharmacy, NH-16, Chilakapalem Jn, Srikakulam-532402, A.P. A B S T R A C T The main aim is to facilitate the regulatory requirements for the approval process of Biosimilar in Regulated and Emerging markets by establishing the foundation for a harmonized regulatory standard to meet ... Read More »

HPLC Estimation of Vildagliptin in Bulk and Pharmaceutical Formulations

Rajkiran Kolakota*, P. Anil Naidu, Uha Rani Duppala Department of Pharmaceutical Analysis, Sri Sivani College of Pharmacy, NH-16, Chilakapalem Jn, Srikakulam-532402, AP  A B S T R A C T A simple and reproducible method was developed for Vildagliptin by Reverse Phase High Performance Liquid Chromatography (RP-HPLC). Vildagliptin was separated on Altima C18 column (150 x 4.6mm, 5μm), using Phosphate ... Read More »

Evaluation of Anti Hypertensive Activity of Thespesia Populena Leaf Extract on Albino Rats

K. Sumanth Kumar*, P. Venkatesh, S. Bhavyasri, P. Sravani Chowdary, P. Pragathi Reddy, E. Nagarjuna, D. Vamsee Krishna Jagans Institute of Pharmaceutical Sciences, Jangala kandriga (V), S.P.S.R Nellore-524346 A B S T R A C T Hypertension remains a major health problem in most countries because of its impact on the population mortility and morbidity. Hypertension is becoming one of ... Read More »

HPLC Estimation of Levofloxacin in Bulk and Pharmaceutical Formulations

Rajkiran Kolakota*, Y. Rupavathi Department of Pharmaceutical Analysis, Sri Sivani College of Pharmacy, NH-16, Chilakapalem Jn, Srikakulam-532402, A.P ABSTRACT A HPLC method was developed and validated to determine trace amounts of levofloxacin related substances & degradation products in its formulation. Separation of levofloxacin from impurity A, impurity B, impurity C and unknown degradation products was achieved on a YMC-Pack Pro ... Read More »

HPLC Estimation of Paroxetine in Bulk and Pharmaceutical Formulations

Rajkiran Kolakota*, P. Anil Naidu, Uha Rani Duppala Department of Pharmaceutical Analysis, Sri Sivani College of Pharmacy, NH-16, Chilakapalem Jn, Srikakulam-532402, AP A  B  S  T  R A C T A simple and reproducible method was developed for Paroxetine by Reverse Phase High Performance Liquid Chromatography (RP-HPLC). Paroxetine was separated on ODS column (150 x 4.6 mm, 5μm), using Phosphate ... Read More »

Scroll To Top